| Sydney Tigges, PT, DPT | |
|
1880 Radford Rd, Dubuque, IA 52002-2272 | |
| (563) 587-8317 | |
| Not Available |
| Full Name | Sydney Tigges |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 1880 Radford Rd, Dubuque, Iowa |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174249718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 114114 (Iowa) | Primary |
| Provider Name | Cv Physical Therapy Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1003326299 PECOS PAC ID: 7810258316 Enrollment ID: O20180226000575 |
News Archive
At times this winter, the greater Salt Lake City area has harbored the most polluted air in the United States. Now, researchers from the University of Utah and other institutions are starting a three-year, $1.3 million study to better understand the winter weather "inversion" conditions frequently associated with poor air quality.
Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sydney Tigges, PT, DPT 1980 Carter Rd, Dubuque, IA 52001-3905 Ph: (563) 513-9410 | Sydney Tigges, PT, DPT 1880 Radford Rd, Dubuque, IA 52002-2272 Ph: (563) 587-8317 |
News Archive
At times this winter, the greater Salt Lake City area has harbored the most polluted air in the United States. Now, researchers from the University of Utah and other institutions are starting a three-year, $1.3 million study to better understand the winter weather "inversion" conditions frequently associated with poor air quality.
Alexion Pharmaceuticals today announced that the U.S. Food and Drug Administration has granted an orphan drug designation to Soliris (eculizumab), a first-in-class terminal complement inhibitor, for the prevention of delayed graft function in renal transplant patients.
Carbylan BioSurgery, Inc. announced today the completion of patient enrollment in their double-blinded, multi-center COR1.0 feasibility trial to evaluate the safety and effectiveness of two products - Hydros and Hydros TA Joint Therapies - in patients with osteoarthritis of the knee. Hydros and Hydros TA are next generation viscosupplement and viscosupplement/steroid combination products.
Albireo today announced that additional clinical data will be reported from a recent study assessing the safety, tolerability and efficacy of A3309 in patients with chronic constipation. A3309 is a first-in-class investigational compound for the treatment of irritable bowel syndrome with constipation (IBS-C) and chronic constipation (CC). The results will be presented during the 2010 Digestive Disease Week (DDW) annual meeting being held in New Orleans, US.
› Verified 2 days ago
Christa Beth Claussen, PT, ATC Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 444 N Grandview Ave, Dubuque, IA 52001 Phone: 563-589-2497 Fax: 563-557-2834 | |
Shannon Custer, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4005 Westmark Dr, Suite 320, Dubuque, IA 52002 Phone: 563-588-3891 Fax: 563-588-3893 | |
Patricia Pape, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2935 Kaufmann Ave, Dubuque, IA 52001 Phone: 563-556-0673 | |
Jason E. Meyer Physical Therapy Doing Bussiness As Dubuque Physical Th Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4005 Westmark Dr, Suite 320, Dubuque, IA 52002 Phone: 563-588-3891 Fax: 563-588-3893 | |
Mrs. Amy Marie Mcfadden-decker, P.T. Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 444 N Grandview Ave, Dubuque, IA 52001 Phone: 563-589-2497 | |
Unified Therapy Health Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4135 Pennsylvania Ave, Dubuque, IA 52002 Phone: 563-583-4003 Fax: 563-265-5789 | |
Molly E Hoppenjan, P.T Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2300 John F Kennedy Rd, Dubuque, IA 52002 Phone: 563-588-3891 Fax: 563-588-3893 |